Effect of Bromocriptine on Left Ventricular Function in Women With Peripartum Cardiomyopathy A Randomized, Controlled Clinical Trial to Evaluate the Efficacy and Safety of Bromocriptine for Improvement of Left Ventricular Function of Women With PPCM.

Trial Profile

Effect of Bromocriptine on Left Ventricular Function in Women With Peripartum Cardiomyopathy A Randomized, Controlled Clinical Trial to Evaluate the Efficacy and Safety of Bromocriptine for Improvement of Left Ventricular Function of Women With PPCM.

Completed
Phase of Trial: Phase II

Latest Information Update: 21 Nov 2016

At a glance

  • Drugs Bromocriptine (Primary)
  • Indications Cardiomyopathies
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Apr 2016 Status changed from recruiting to completed.
    • 16 Nov 2011 Additional lead trial centre identified as reported by European Clinical Trials Database.
    • 26 Aug 2011 New source identified and integrated (German Clinical Trials Register).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top